Clinical Trials Blog from Applied Clinical Trials

Where There's Room for Discussion

The Trusted Clinical Trials Business Report

home: :subscribe: :about us: :

rss feeds/xml

Search
Suppliers
Careers

About Search

- Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
- News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
- News, developments and strategies related to eClinical, data management, data collection, ePRO, and more information technology used in the drug development chain. Go→
- News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
- News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
- News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→

Rodney Dangerfield and R&D

By Kerri Nelen | Published: February 3, 2010

Once again we turn to our sister blog PharmTechTalk and a blog from Erik Greb, who discusses the plight of today’s research scientists as they face more cuts.

This entry was posted in CRO/Sponsor and tagged drug development, R&D, research scientists. Bookmark the permalink. Post a comment or leave a trackback: Trackback URL.

Share |

Post a Comment

Your email is never published nor shared. Required fields are marked *

Name *

Email *

Website

Comment

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Categories
Recent Posts
Recent Comments
Tags

CBI China conference CRO/Sponsor CROs data DIA diabetes drug development eClinical EDC EMA emerging region EU Europe European Medicines Agency facebook FDA India IT Kayda Norman Ken Getz Lisa Henderson London oncology Oracle patient/subject recruitment patients Peter O'Donnell Pfizer Pharmaceutical Executive Pharmaceutical Technology Philip Ward PRO R&D Regulatory REMS Sites social media subject recruitment technology Thomas Lönngren Tim Denman UK Wayne Kubick
Join ACT for discussions, news, and more on

Facebook LinkedIn Twitter

About Us

The Applied Clinical Trials blog brings to you an area of discussion on news and analysis of the business of the clinical trials industry. Along with special guest blogs to come, our primary writers are Lisa Henderson, Editor in Chief; Tim Denman, Managing Editor; Kayda Norman, Associate Editor; Philip Ward, European Editor; Wayne Kubick, Technology Viewpoint Columnist; and Peter O'Donnell, View from Brussels Columnist.
Editor's Choice Blog Sites
Archives

Rodney Dangerfield and R&D

Post a Comment

Categories

Recent Posts

Recent Comments

Tags

Join ACT for discussions, news, and more on

About Us

Editor's Choice Blog Sites

Archives